Cytokinetics
NASDAQ: CYTK1 known investors
Cytokinetics is a biopharmaceutical company focused on muscle biology, developing small molecule muscle activators and inhibitors to treat diseases involving compromised muscle function, including heart failure, hypertrophic cardiomyopathy, and neuromuscular diseases.
BiotechHealthtech
Investors · 1
In the news
How Investors May Respond To Cytokinetics (CYTK) UK MYQORZO Approval Amid Wider Quarterly Loss - Simply Wall St Newssimplywall.st · Aug 2026Frequently asked questions
- What does Cytokinetics do?
- Cytokinetics is a biopharmaceutical company focused on muscle biology, developing small molecule muscle activators and inhibitors to treat diseases involving compromised muscle function, including heart failure, hypertrophic cardiomyopathy, and neuromuscular diseases.
- Who are Cytokinetics's investors?
- Cytokinetics's investors include Foresite Capital.